These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 119594)

  • 1. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
    Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between TRH and dopaminergic drugs on growth hormone secretion rise in some pathologic conditions of the animal and man.
    Cocchi D; Salerno F; Casanueva F; Zanardi P; Parati EA; Müller EE
    Pharmacol Res Commun; 1980 Apr; 12(4):397-402. PubMed ID: 6771776
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone releasing activity of thyrotropin-releasing hormone in rats with hypothalamic lesions.
    Müller EE; Panerai AE; Cocchi D; Gil-Ad I; Rossi GL; Olgiati VR
    Endocrinology; 1977 Jun; 100(6):1663-71. PubMed ID: 404131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
    Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly.
    Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):43-7. PubMed ID: 3115634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F; Picotti GB; Massara F; Molinatti GM; Mantegazza P; Müller EE
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
    Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
    Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):636-47. PubMed ID: 99332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H; Tamura T; Sasaki S; Takebe K
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S; Nilsson KO; Rannevik G; Wide L
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotrophin releasing hormone-induced growth hormone and prolactin release: physiological studies in intact rats and in hypophysectomized rats bearing an ectopic pituitary gland.
    Panerai AE; Gil-Ad I; Cocchi D; Locatelli V; Rossi GL; Müller EE
    J Endocrinol; 1977 Mar; 72(3):301-11. PubMed ID: 404376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.
    Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M
    Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic hormone interaction in acromegaly.
    Gomez-Pan A; Tunbridge WM; Duns A; Hall R; Besser GM; Coy DH; Schally AV; Kastin AJ
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):455-60. PubMed ID: 170027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.